- Home
- EXEL vs MGA Comparison
EXEL vs MGA Comparison
Compare EXEL & MGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- MGA
- Stock Information
- Founded
- EXEL 1994
- MGA 1957
- Country
- EXEL United States
- MGA Canada
- Employees
- EXEL 1147
- MGA N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- MGA Auto Parts:O.E.M.
- Sector
- EXEL Health Care
- MGA Consumer Discretionary
- Exchange
- EXEL Nasdaq
- MGA Nasdaq
- Market Cap
- EXEL 10.4B
- MGA 11.5B
- IPO Year
- EXEL 2000
- MGA N/A
- Fundamental
- Price
- EXEL $38.31
- MGA $44.30
- Analyst Decision
- EXEL Buy
- MGA Hold
- Analyst Count
- EXEL 21
- MGA 14
- Target Price
- EXEL $43.65
- MGA $41.86
- AVG Volume (30 Days)
- EXEL 4.0M
- MGA 1.5M
- Earning Date
- EXEL 07-28-2025
- MGA 08-01-2025
- Dividend Yield
- EXEL N/A
- MGA 4.36%
- EPS Growth
- EXEL 81.76
- MGA 24.01
- EPS
- EXEL 2.08
- MGA 4.26
- Revenue
- EXEL $2,230,005,000.00
- MGA $41,608,000,000.00
- Revenue This Year
- EXEL $9.88
- MGA N/A
- Revenue Next Year
- EXEL $12.59
- MGA $2.59
- P/E Ratio
- EXEL $18.45
- MGA $10.31
- Revenue Growth
- EXEL 10.73
- MGA N/A
- 52 Week Low
- EXEL $25.12
- MGA $30.39
- 52 Week High
- EXEL $49.62
- MGA $47.22
- Technical
- Relative Strength Index (RSI)
- EXEL 41.08
- MGA 64.65
- Support Level
- EXEL $37.01
- MGA $42.00
- Resistance Level
- EXEL $38.78
- MGA $45.33
- Average True Range (ATR)
- EXEL 1.12
- MGA 0.92
- MACD
- EXEL 0.07
- MGA 0.18
- Stochastic Oscillator
- EXEL 83.79
- MGA 78.63
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About MGA Magna International Inc.
Magna International prides itself on an entrepreneurial culture and a corporate constitution that outlines the distribution of profits to various stakeholders. This automotive supplier's product groups include exteriors, interiors, seating, roof systems, body and chassis, powertrain, vision and electronic systems, closure systems, electric vehicle systems, tooling and engineering, and contract vehicle assembly. In 2024, 48% of Magna's USD 42.8 billion of revenue came from North America, while Europe accounted for approximately 37% and Asia the remainder. The firm's top six customers constituted 72.9% of revenue, with the top three being GM, Mercedes, and Ford. GM was the largest contributor at 15.4%. Magna was founded in 1957, has over 170,000 employees, and is based in Aurora, Ontario.